Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NAII
NAII logo

NAII Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Natural Alternatives International Inc (NAII) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.800
1 Day change
2.94%
52 Week Range
4.960
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Natural Alternatives International Inc (NAII) is not a strong buy for a beginner, long-term investor at this time. While the company has shown slight improvements in financial performance, the lack of significant trading trends, neutral technical indicators, and no strong proprietary trading signals suggest that the stock does not currently present a compelling entry point. Additionally, the stock's short-term trend indicates potential downside risk in the next month, making it less attractive for immediate investment.

Technical Analysis

The MACD is slightly positive at 0.0165 but contracting, indicating weakening momentum. RSI is neutral at 54.174, and moving averages are converging, showing no clear trend. Key support and resistance levels are at 2.63 and 2.882, respectively, with the stock trading near its pivot point of 2.756. Overall, the technical indicators suggest a neutral outlook.

Positive Catalysts

  • The launch of CarnoSyn® 4X with improved bioavailability could expand the consumer base and enhance revenue potential in the long term.

Neutral/Negative Catalysts

  • The stock has a 70% chance of declining by -7.1% over the next month based on historical patterns. Additionally, there are no significant trading trends from hedge funds or insiders.

Financial Performance

In Q2 2026, revenue increased by 2.10% YoY to $34,795,000. Net income improved by 16.52% YoY but remains negative at -$2,553,000. EPS also improved by 13.51% YoY to -0.42, and gross margin increased significantly by 46.12% YoY to 7.16%. While there is some improvement, the company is still operating at a loss.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available.

Wall Street analysts forecast NAII stock price to rise
Analyst Rating
0
Wall Street analysts forecast NAII stock price to rise
Buy
Hold
Sell
0
Current: 2.720
sliders
Low
0
Averages
0
High
0
0
Current: 2.720
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch